NCT02158104

Brief Summary

Pain after dry needling or injection in the muscle is a frequent secondary effect in the treatment of myofascial pain syndrome. In this trial pain and sensitivity will be assessed during a 72 hours follow up period. Factors that may contribute to higher levels of pain or sensitivity will be evaluated.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2013

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2014

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

June 5, 2014

Completed
1 day until next milestone

First Posted

Study publicly available on registry

June 6, 2014

Completed
Last Updated

June 6, 2014

Status Verified

January 1, 2014

Enrollment Period

4 months

First QC Date

June 5, 2014

Last Update Submit

June 5, 2014

Conditions

Outcome Measures

Primary Outcomes (1)

  • Pain

    Visual analogue scale

    72 hours

Secondary Outcomes (1)

  • Sensitivity

    72 hours

Study Arms (1)

Latent trigger point in the upper trapezius muscle

Procedure: Deep dry needling

Interventions

Latent trigger point in the upper trapezius muscle

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Healthy subjetct. Community sample from university.

You may qualify if:

  • The latent MTrP diagnosis was based upon the following criteria:10
  • presence of a palpable taut band in the muscle
  • presence of a hypersensitive tender spot in the taut band
  • palpable or visible local twitch response with snapping palpation of the tout band
  • referred pain elicitation in response to compression.

You may not qualify if:

  • presence of coagulation disorders
  • neck or facial pain
  • previous application of a dry needling technique
  • MTrP therapy in head or neck within the previous 3 months
  • fibromyalgia
  • an insurmountable fear of needles as a reason of refusing the treatment
  • history of surgery in the head or neck area.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 5, 2014

First Posted

June 6, 2014

Study Start

October 1, 2013

Primary Completion

February 1, 2014

Last Updated

June 6, 2014

Record last verified: 2014-01